Thompson Davis & Co’s Vascular Solutions Inc VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-500
Closed -$28K 1310
2016
Q4
$28K Sell
500
-1,540
-75% -$78.5K 0.05% 383
2016
Q3
$98K Hold
2,040
0.17% 138
2016
Q2
$85K Buy
2,040
+1,540
+308% +$57.3K 0.14% 159
2016
Q1
$16K Sell
500
-250
-33% -$7.21K 0.02% 531
2015
Q4
$26K Sell
750
-8,530
-92% -$289K 0.04% 392
2015
Q3
$301K Buy
9,280
+8,530
+1,137% +$306K 0.42% 60
2015
Q2
$26K Hold
750
0.03% 478
2015
Q1
$23K Buy
750
+250
+50% +$7.18K 0.03% 501
2014
Q4
$14K Hold
500
0.02% 650
2014
Q3
$12K Hold
500
0.02% 651
2014
Q2
$11K Hold
500
0.02% 479
2014
Q1
$13K Hold
500
0.02% 455
2013
Q4
$12K Buy
+500
New +$9.8K 0.02% 431

Other funds holding VASC

Thompson Davis & Co's VASC Position: Q1 2017 in Review

Thompson Davis & Co sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 500 shares — an estimated $28K sold.

Thompson Davis & Co first reported a position in VASC in Q4 2013 and held it in 13 quarters. The position peaked at $301K in Q3 2015. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • Thompson Davis & Co reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 500 Vascular Solutions Inc shares in Q1 2017, an estimated $28K.
  • Thompson Davis & Co first reported a position in Vascular Solutions Inc in Q4 2013 and held it in 13 quarters.
  • Thompson Davis & Co's Vascular Solutions Inc position peaked at $301K in Q3 2015.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on Thompson Davis & Co's 13F filing for Q1 2017, filed 8 May 2017.